Fate Therapeutics Stock Market Value
| FATE Stock | USD 1.40 0.03 2.19% |
| Symbol | Fate |
Will Biotechnology sector continue expanding? Could Fate diversify its offerings? Factors like these will boost the valuation of Fate Therapeutics. Market participants price Fate higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Fate Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.37) | Revenue Per Share | Quarterly Revenue Growth (0.43) | Return On Assets | Return On Equity |
The market value of Fate Therapeutics is measured differently than its book value, which is the value of Fate that is recorded on the company's balance sheet. Investors also form their own opinion of Fate Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Fate Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Fate Therapeutics' market value can be influenced by many factors that don't directly affect Fate Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fate Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fate Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Fate Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Fate Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fate Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fate Therapeutics.
| 11/22/2025 |
| 02/20/2026 |
If you would invest 0.00 in Fate Therapeutics on November 22, 2025 and sell it all today you would earn a total of 0.00 from holding Fate Therapeutics or generate 0.0% return on investment in Fate Therapeutics over 90 days. Fate Therapeutics is related to or competes with Nkarta, Alector, Vor Biopharma, Cassava Sciences, Prelude Therapeutics, Inovio Pharmaceuticals, and PepGen. Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for ca... More
Fate Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fate Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fate Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.47 | |||
| Information Ratio | 0.1231 | |||
| Maximum Drawdown | 22.03 | |||
| Value At Risk | (7.56) | |||
| Potential Upside | 8.0 |
Fate Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fate Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fate Therapeutics' standard deviation. In reality, there are many statistical measures that can use Fate Therapeutics historical prices to predict the future Fate Therapeutics' volatility.| Risk Adjusted Performance | 0.1133 | |||
| Jensen Alpha | 0.5152 | |||
| Total Risk Alpha | 0.2983 | |||
| Sortino Ratio | 0.1266 | |||
| Treynor Ratio | 0.3176 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Fate Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Fate Therapeutics February 20, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1133 | |||
| Market Risk Adjusted Performance | 0.3276 | |||
| Mean Deviation | 3.64 | |||
| Semi Deviation | 3.83 | |||
| Downside Deviation | 4.47 | |||
| Coefficient Of Variation | 730.19 | |||
| Standard Deviation | 4.6 | |||
| Variance | 21.14 | |||
| Information Ratio | 0.1231 | |||
| Jensen Alpha | 0.5152 | |||
| Total Risk Alpha | 0.2983 | |||
| Sortino Ratio | 0.1266 | |||
| Treynor Ratio | 0.3176 | |||
| Maximum Drawdown | 22.03 | |||
| Value At Risk | (7.56) | |||
| Potential Upside | 8.0 | |||
| Downside Variance | 19.98 | |||
| Semi Variance | 14.63 | |||
| Expected Short fall | (4.50) | |||
| Skewness | 0.1573 | |||
| Kurtosis | 0.1292 |
Fate Therapeutics Backtested Returns
Fate Therapeutics appears to be very risky, given 3 months investment horizon. Fate Therapeutics secures Sharpe Ratio (or Efficiency) of 0.12, which denotes the company had a 0.12 % return per unit of risk over the last 3 months. By reviewing Fate Therapeutics' technical indicators, you can evaluate if the expected return of 0.55% is justified by implied risk. Please utilize Fate Therapeutics' Mean Deviation of 3.64, downside deviation of 4.47, and Coefficient Of Variation of 730.19 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Fate Therapeutics holds a performance score of 9. The firm shows a Beta (market volatility) of 1.95, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Fate Therapeutics will likely underperform. Please check Fate Therapeutics' semi variance, and the relationship between the maximum drawdown and accumulation distribution , to make a quick decision on whether Fate Therapeutics' price patterns will revert.
Auto-correlation | 0.05 |
Virtually no predictability
Fate Therapeutics has virtually no predictability. Overlapping area represents the amount of predictability between Fate Therapeutics time series from 22nd of November 2025 to 6th of January 2026 and 6th of January 2026 to 20th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fate Therapeutics price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current Fate Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.05 | |
| Spearman Rank Test | -0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Fate Therapeutics is a strong investment it is important to analyze Fate Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fate Therapeutics' future performance. For an informed investment choice regarding Fate Stock, refer to the following important reports:Check out Fate Therapeutics Correlation, Fate Therapeutics Volatility and Fate Therapeutics Performance module to complement your research on Fate Therapeutics. For information on how to trade Fate Stock refer to our How to Trade Fate Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Fate Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.